Stocktoria
Divi's Laboratories Limited DIVISLAB.NS
IN · National Stock Exchange of India · XNSE · stock · Healthcare · website
Divi's Laboratories Limited statistics & valuation
Market cap₹1.74T
P / E67.7×
P / S16.5×
P / B10.4×
P / FCF797.1×
Dividend yield0.46%
Net margin24.3%
Return on equity15.3%
FCF margin2.1%
Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
Divi's Laboratories Limited trades at about 68× earnings — near its 10-year norm (10-year range 47.6×–73.8×, median 67.2×).
47.6×
73.8×
Shaded band = 10-year range (47.6×–73.8×); dot = today's 68×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Gross margin | 61.2% | 60.2% | 58.1% | 58.5% |
| Operating margin | 28.2% | 27.4% | 23.5% | 26.4% |
| Net margin | 24.3% | 23.4% | 20.5% | 23.8% |
| FCF margin | 2.1% | 2.3% | 3.3% | 25.9% |
| Return on assets | 12.8% | 12.9% | 10.3% | 12.6% |
| Return on equity | 15.3% | 14.6% | 11.8% | 14.3% |
| Current ratio | 5.43 | 6.94 | 7.57 | 8.46 |
Source: company filings via Yahoo Finance · IN · as of 2026-03-31. Figures in INR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.